vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

VTVT | NASDAQ
Chart Builder DCF Calculator
$31.10
-$0.20 (-0.64%)
At close: Sep 22, 2026, 4:00 PM ET
$31.10
$0 (0.00%)
After-hours: Sep 22, 2026, 4:27 PM ET

Market Data

Market Cap
$81.92M
Enterprise Value
$-4.72M
Beta
0.29
Average Volume
64.6K
Shares Outstanding (Diluted)
12.41M
Shares Change YoY
88.39%
Institutional Ownership
17.66%
Exchange
NASDAQ
ISIN
US9183852048

Price Performance

Price Change 1M
-5.2%
Price Change 3M
-11.4%
Price Change 6M
-18.3%
Price Change YTD
-21.0%
Price Change 1Y
41.2%
Price Change 3Y
77.8%
Price Change 5Y
-57.2%
1M CAGR (ann.)
-11.5%
1Y CAGR (ann.)
46.6%
5Y CAGR (ann.)
-15.3%
All-Time CAGR
-21.0%

Valuation

PE Ratio
-284.55
Forward PE
N/A
PEG Ratio
0.27
Forward PEG
-1.33
PS Ratio
2.22
Forward PS
102.40
PB Ratio
1.04
P/FCF Ratio
-10.77
P/Adj. FCF Ratio
-6.42
P/OCF Ratio
-23.19
EV/Sales
-0.13
EV/EBIT
0.74
EV/EBITDA
0.74
EV/FCF
0.62
Earnings Yield
-0.3%
FCF Yield
-9.3%
Adj. FCF Yield
-15.6%

Financial Health

Net Cash
$86.64M
Total Debt
$0
Cash & Short-Term Investments
$86.64M
Total Assets
$87.59M
Current Ratio
12.48
Quick Ratio
12.48
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-1,541.83
Altman Z-Score
1.72
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-25.1%
EBITDA Margin
-17.4%
Net Profit Margin
-12.9%
FCF Margin
-20.6%
Adj. FCF Margin
-34.6%
SBC / Revenue
14.0%
SBC Impact (per share)
-67.7%

Returns

Return on Assets
-5.4%
Return on Equity
-6.3%
Return on Invested Capital
-11.5%
Return on Capital Employed
-11.5%
Return on Tangible Assets
-5.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
1499.6%
Revenue CAGR 5Y
37.9%
Revenue CAGR 10Y
44.7%
EPS CAGR 3Y
99.8%
EPS CAGR 5Y
45.5%
EPS CAGR 10Y
32.8%
FCF CAGR 3Y
41.4%
FCF CAGR 5Y
4.6%
FCF CAGR 10Y
12.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
14
EPS Growth Next 3Y
-1618.2%
Revenue Growth Next 3Y
-52.7%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$1.16
EPS Growth Est (next Q)
7.4%
Revenue Est (next Q)
$333.33K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$42
Price Target Upside
34.2%

Cash Flow

Operating Cash Flow
$-7.61M
Free Cash Flow
$-7.61M
Adj. Free Cash Flow
$-12.75M
FCF Per Share
-$1.35
OCF Per Share
-$1.35
OCF/S Ratio
-45.5%

Income Statement

Revenue
$36.84M
Gross Profit
$36.84M
Operating Income
$-9.25M
EBITDA
$-6.39M
Net Income
$-4.76M
EPS (Diluted)
-$0.11
Revenue / Employee
$1.42M
Profit / Employee
$-182.92K
Employees
26

© 2026 bestshares.com. All rights reserved.